Review Article

Risk Factors of Multidrug-Resistant Bacteria in Lower Respiratory Tract Infections: A Systematic Review and Meta-Analysis

Table 1

The baseline characteristics of included studies.

Study IDYearStudy typeCountriesNo. of centersSettingPopulationNo. of patientsNo. of MDROsMDR strainsAge (years)aMale (%)

Villafuerte and Aliberti [16]2019Prospective54 countries222Internal and emergency medicine, infectious diseases, critical care and pulmonary medicineCAP319338EB68.0 (54.0, 80.0)58.8
Restrepo et al. [17]2017Prospective54 countries222Internal and emergency medicine, infectious diseases, critical care and pulmonary medicineCAP13333PA64.4 (52.5, 78.5)59.4
Feng et al. [26]2019RetrospectiveChinaSinglePulmonary and critical care medicine, surgical ICUHAP313193EB, SANA72.5
VAP10678EB, SANA67.0
Zhou et al. [27]2018RetrospectiveChinaSingleInstitute of Respiratory Diseases, Division of Respiratory Diseases of Department of Internal Medicine, Department of PediatricsHAP15769PA57.8 ± 17.871.3
Luan et al. [28]2018RetrospectiveChinaSingleDepartment of Infectious DiseasesCAP17629EB, SA, SP68.3 ± 4.353.4
Lewis et al. [29]2018RetrospectiveUSASingleTrauma ICUVAP397135AB, PA45.0 (16.0, 85.0)78.0
Gao et al. [30]2018RetrospectiveChinaSingleDepartment of Respiratory and Critical Care Medicine, Department of Emergency MedicineBronchiectasis8834PA59.7 ± 18.252.3
Song et al. [31]2017RetrospectiveKorea3NAHDAP10524GPB & GNB71.0 (61.0, 76.0)64.8
Fernandez-Barat et al. [32]2017ProspectiveSpainSingleMedical and surgical ICUsICUAP6422PA66.0 ± 15.073.4
Huang et al. [33]2016RetrospectiveChinaSingleMedical ICUPneumonia263154GPB & GNB72.9 ± 14.162.3
Cillóniz et al. [14]2016ProspectiveSpainSingleHospital clinicCAP7722PA71.4 ± 14.684.4
Tedja et al. [34]2014RetrospectiveUSASingleMedical, surgical, cardiovascular, coronary, and neurologic ICUVAP10749GPB & GNB62.0 ± 14.055.0
Özgür et al. [35]2014RetrospectiveTurkeySingleMedical, surgical, adult ICUVAP13434AB53.2 ± 21.059.0
Gross et al. [15]2014RetrospectiveUSASingleAcademic medical centerCAP or HCAP52120GPB & GNB65.0 (52.0, 79.0)44.5
Wang et al. [37]2013ProspectiveChinaSingleTertiary teaching hospitalHAP10224MRSA74.9 ± 12.464.7
Zheng et al. [36]2013RetrospectiveChinaSingleHospital affiliated to a universityPneumonia24297AB61.4 ± 9.854.9
Seligman et al. [38]2013RetrospectiveBrazilSingleTertiary care teaching hospitalHAP14059GPB & GNB63.0 ± 14.470.0
Hamet et al. [39]2012ProspectiveFranceSingleICUVAP32390GPB & GNB63.4 ± 15.266.9
Shi et al. [40]2010ProspectiveChinaSingleHospital affiliated to a universityPneumonia47557GNB42.6 ± 11.389.7
Depuydt et al. [41]2008ProspectiveBelgiumSingleMedical and surgical ICUVAP19252GPB & GNB59.4 ± 16.171.9
Nseir and Ader [42]2006ProspectiveFranceSingleICUAECOPD78869GPB & GNB66.2 ± 11.976.8

aMean ± SD or median (IQR); MDR: multidrug resistance; MDROs: multidrug-resistant organisms; no.: number; ICU: intensive care unit; CAP: community-acquired pneumonia; HAP: hospital-acquired pneumonia; VAP: ventilator-associated pneumonia; HDAP: hemodialysis-associated pneumonia; ICUAP: intensive care unit-acquired pneumonia; HCAP: healthcare-associated pneumonia; AECOPD: acute exacerbation of chronic obstructive pulmonary disease; GNB: Gram-negative bacteria; GPB and GNB: Gram-negative bacteria and Gram-positive bacteria; EB: Enterobacteriaceae; PA: Pseudomonas aeruginosa; SA: Staphylococcus aureus; SP: Streptococcus pneumoniae; MRSA: methicillin-resistant Staphylococcus aureus; AB: Acinetobacter baumannii.